Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammation01:38

Inflammation

62.4K
Overview
62.4K
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

2
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
2
Modified-Release Drug Delivery Systems: Rate-Programmed I01:22

Modified-Release Drug Delivery Systems: Rate-Programmed I

2
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
2
What is the Immune System?01:38

What is the Immune System?

132.7K
Overview
132.7K
Allergic Reactions02:06

Allergic Reactions

32.5K
Overview
32.5K
Mismatch Repair01:36

Mismatch Repair

43.8K
Overview
43.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A pathogenic CD4 T cell phenotype in experimental uveitis shares common features with other immune mediated inflammatory diseases.

Discovery immunology·2026
Same author

Type 3 hybrid effectiveness-implementation study implementing and evaluating the Comprehensive High-dose Aphasia Treatment (CHAT) programme in Australian rehabilitation services: a protocol.

BMJ open·2026
Same author

Network-level disconnectivity tracks poststroke depressive symptom improvement.

Psychiatry and clinical neurosciences·2026
Same author

Can NRF2 provide a gene-agnostic approach to treating age-related macular degeneration?

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Tissue resident memory T cells populate the human uveal tract.

Scientific reports·2026
Same author

The Immunopathogenesis of uveitis.

Frontiers in medicine·2026

Related Experiment Video

Updated: Feb 13, 2026

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.9K

Re-programming immunosurveillance in persistent non-infectious ocular inflammation.

Simon J Epps1, Joanne Boldison2, Madeleine L Stimpson1

  • 1Academic Unit of Ophthalmology, Bristol Medical School, Faculty of Health Sciences, University of Bristol, BS8 1TD, UK.

Progress in Retinal and Eye Research
|March 14, 2018
PubMed
Summary
This summary is machine-generated.

Persistent ocular inflammation, like uveitis, disrupts the eye's immune system and tissue integrity. This reprogramming can lead to severe vision impairment and requires further study for new treatments.

Keywords:
AngiogenesisEAUEctopic lymphoid tissueImmunosurveillanceUveitis

More Related Videos

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
12:23

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses

Published on: September 7, 2022

2.1K
Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.2K

Related Experiment Videos

Last Updated: Feb 13, 2026

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.9K
In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
12:23

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses

Published on: September 7, 2022

2.1K
Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.2K

Area of Science:

  • Ophthalmology
  • Immunology
  • Tissue Engineering

Background:

  • Ocular function relies on anatomical integrity, which is compromised by inflammation.
  • Uveitis, particularly retinal involvement, alters immune surveillance and tissue homeostasis in the eye.
  • Persistent inflammation can lead to ectopic lymphoid-like structures and disrupted angiogenesis.

Purpose of the Study:

  • To understand how persistent ocular inflammation reshapes the ocular environment.
  • To identify changes in immune cell presence and tissue integrity during ocular inflammation.
  • To explore the link between inflammation-induced changes and impaired eye function.

Main Methods:

  • Analysis of human disease and mouse models of uveitis.
  • Histopathological examination for immune cell infiltration and tissue alterations.
  • Assessment of angiogenesis and lymphoid-like structure formation.

Main Results:

  • Inflammation leads to the infiltration of non-resident cell types into the eye.
  • Significant alterations in tissue homeostasis and integrity were observed.
  • Severe cases showed ectopic lymphoid-like structures and disrupted angiogenesis, correlating with impaired eye function.

Conclusions:

  • Persistent ocular inflammation profoundly alters the eye's immune landscape and tissue structure.
  • Understanding these inflammatory mechanisms is key to developing targeted therapies for vision-threatening conditions.
  • Further research is needed to translate these findings into effective treatments for uveitis and related disorders.